Trojan Horse Method Allows Stem Cells to Eradicate Melanoma
For nearly three decades, Synthecon, Inc. has been a leader in 3D cell culture technology through innovating and exploring the potential of the rotary cell culture system as it applies to tissue engineering, stem cell culture, tumor spheroid formation, host-pathogen studies and more. Their role in research has been absolutely vital to these and a broad range of other applications, but particularly regarding those relating to animal and human health.Synthecon Provides Useful Tool for Research Into Cancer and Stem Cell Therapies
The prospect of accessible and effective regenerative medicine offers many patients suffering with degenerative diseases hope where treatment options (or lack thereof) in the past have left a void. There is an imminent and expanding need for therapies to be developed which can solve these debilitating conditions. One company has been helping researchers and clinicians work towards a solution for nearly three decades. Synthecon, Inc. is based in Houston, Texas and is the manufacturer of a very vital piece of medical equipment: a bioreactor. In essence, this piece of machinery helps to produce mature 3D cell cultures which help provide the stepping stones to solve clinical challenges in stem cell therapies, cancer and tissue engineering. The Rotary Cell Culture System (RCCS) suspends cells in a microgravity-like environment, and was originally developed at NASA. Initially intended to study astronaut health in space, researchers soon realized that the technology had far broader applications with respect to animal and human health – chiefly because the 3D organization of cells in the bioreactor allows for a more accurate understanding of how cells behave in the body here on earth.